Adrenocorticotropic hormone receptor and uses
CA 2388198 A1 · Owner: State Of Oregon, Acting By And Through The Oregon State Board · Inventors: Mountjoy, Kathleen G.; Cone, Roger D.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention rotates to a mammalian adrenocorticotropic hormone receptor. The invention is directed toward the isolation, characterization and pharmacological use of mammalian adrenocorticotropic hormone receptor, the gene corresponding to this receptor a, recombinant eukaryotic expression construct capable of expressing a mammalian-adrenocorticotropic hormone receptor in cultures of transformed eukaryotic cells and such cultures of transformed eukaryotic cells that synthesize mammalian adrenocorticotropic hormone receptor. The invention also provides methods for screening ACTH R agonists and antagonists in vitro using preparations of receptor from such cultures of eukaryotic cells …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 7, 1993. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 7, 2013.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 7, 2015.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.